Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
SRPioneers O Science and Research Pioneers Institute, (www.srpioneers.org) ICN2OI4 CtrRTIFICATION This certification is awarded to Mrs/Mr Shokoofeh Geranmayeh (with affiliation of the department of chemistry, AIzaIva University, Tehran, Iran) [] for acceptance and fully registration of the paper with the title of Investigation the cytotoxicity and release of 5-FU loaded nanoporous metal-organic framework and co-authors of Ahreza Abbasi, Amir-Hassan Zarnani, Zotueh Mohammadi tnZnd International Conference on Nanotechnolo gy (ICN 20 1 4) \#a Supervisor Signature lry ,) $.Ilf; l?-l},Pi$'t $*,,,u,i,,,,* SRPioneers @ Science and Resealch Pioneers Institute (wrvrv.srpioneers.org) lnd lnle rnuior;ai {.lonibreucs on Nmotcchnolorv (lCN :01 4 ), I ()- I I Jlriy lr) 14, lsranllr l. 'i'u rh".y Investigation the cytotoxiciQ and release of 5-FU loaded nanoporous metal-organic framework Shokoofeh Gerarulayeh Department of chemistry Alzahra University Tehran, Iran A\reza Abbasi Amir-Has san Zarnam, Zohr eh Mohammadi School of chemistry, college of science University of Tehran Tehran, Iran Abstract-Metal-Organic Frameworks (MOFs) are emerging as a powerful platform for delivery and release of several drug molecules. Herein we report the ultrasonic preparation of new nano-sized metal-organic framework (NMOF, l) as drug carrier and the potential cytotoxicity of I was evaluated on human amniotic epithelial cells (hAECs) by XTT assay, The results clearly shorved that this compound exerted little in vitro cytotoxic effcct in a wide range of concentration and tinre intervals, implying excellent biocompatibility. Therefore, this matrix can be regarded as a sal'e carrier for drug delivery systen.rs. We also report the incorporation of the anti-cancer drug 5- Fluorouracil (5-FU) into the newly prepared carrier with high load and progressive release. Adsorption that 5-FU is incorporated into MOF 22.8204. 5-FU is released in a progressive fashion rvith 40"/" of the drug release after 12 measurements shorv with a load content of hours Due to this lack of toxicity results of MOFs, herein we report a nerv crystal structure derived from the zinc- 4,4'biphenyldicarboxylic acid-dimethylformamid system, and investigate its toxicity and possibility for biomedical applications. The cytotoxicity of the studied con.rpound has been evaluated and its possibility of being as a caffler in drug delivery systems discussed. Furthermore, the drug loading and delivery I. INTRODUCTION Metal-organic frameworks (MOF0 represent an incredibly growing class of nanoporous materials and are the latest class of ordered porous compounds. The drive behind this rapid development lies on the irnportant specific structures, properties and potential applications.[ 1] Frnnr tlre svrrtlretin noirrl nf view di .nd tl icarboxylates are one of the most successflil classes of polytopic ligands in designing MOFs due to the relatively labile M-O bonds. E,ven though the reactions of nany transition metals with dicalboxylates have been srudied, those of Zn-based MOFs have been mainly significant. Yaghi and co-wolkers have reported a number of interesting sttuchues based on zinc that show remarkable methane and hydrogen adsorption properties.[2] Although industrial applications of this type of MOFs have so far been well srudied, toxiciff results dealing with MOFs or coordination polyrners al'e very scarce.[3] In general, the use ofporous solids for biomedical applications lequiles a biologicrlly fliendly conrpositiorr. of the compound have been investigated. II. MATERIALS AND METHoDS Most of the reagents were acquired from Merck and used as received. Dimethyl sulfoxide (DMSO) were obtained from Sigrna. fronr GIBCO.The solvents were purified prior to use. A multi-wave ultrasonic 3200;Bandeline, Keywords-cotnponett; tlrug tlelivery; nanoparticle; ntetalorgattic frametuork; 5-FU Nanobiotechnology Research Center, Avicenna Research Institute (ACECR) Tehran, Iran genel'ator (Sonicator KE 76, Germany), equipped with a converter/transducer and titanium oscillator (horn), 6 mm in diameter, operating at 50/60 Hz with a maximum power output of 200 W, was used for the ultlasonic irradiation. Scaming electron microscopy (SEM) observations were performed by Oxfold LEO 1445 V. Synthesis of [Zn3@pdc)a], 1. A mixture of Zn(NO3)2.6H2O (0.29Ig, lmmol), C12H16Oa Q.2429, 2mmol) in 10 mL of DMF were sealed in Teflonelined autoclave and heated under autogenous pressure to 120"C for four days. After the rnixture was cooled to room temperahre at a rate of 6'Clh, colorless crystal of the compound were collected, washed with ethanol, and dried at room temperature to give 82.3 % yield based on Zn(NO3)2.6H2O. In order to get the nanoparticle of l, the solution containing crystals of compound, exposed by ultrasonrc irradiation at diffetent power at roonl temperature for various time. The white precipitates were cenh'ifuged, washed with ethanol and dried at 50'C. Dissolving 5-Fu (25mg) and desoh'ated 1 (25mg) in methanol (5ml). Then the rnixture rvas centrifuged and the solid washed with methanol. The 5-FU content calculated tluough llV/Vis results. was 15 mg of drug loaded I was dissolved into 5 rnl- of PBS buffer solr-rtion @H:7.4). During each time interval, '/l-/,'.'''/),,,.,,, SRPioneers @ Science and Research Pioneers Institute (nrwv.sr.pioneers.org) ind hiternrtiorr;rl (lonlbleuce on N:rnotech nology ilON 2i) I4 ), I {)* i I ftriy l0 14, Irtlnlu rl. 'l'u r{iey ca. 200 rnicloliter was pulled out to test. The content of 5- FU in the sarnples taken out was monitored by fluorometery in rvhich the detection wavelength was 453run.. III. RESULTS AND DISCUSSION X-ray single crystal determination of structure I shows a neutral 3D metal-organic network which crystallizes rn the orthorombic system, space group Pna21 [4]. The structure comprise of two crystallographically independent Zn(II) atoms forming Trinuclear zinc carboxylate as SBUs. The distorted Zn(1) center is coordinated by four oxygen atoms which associate with four bpdc ligands. the distorted octahedral Zn (2) centers are coordinated by six oxygen atoms , which associate with six bpdc (fig 1). This arrangement forming the 3-dimensional skeleton with two-dimensional porous system with channels characterized by dimensions of 5 x 8 A, based on the Zn...Zn separation (excluding van der Waals radii) (fig. 2). Based on a PLATON [5] analysis (filling of the cavities with probe spheres of radius 1.2 A), the fi'ee volume in the absence of guest molecules was found to be 49.1%. Fig. 2. 3-dirnensional skeleton with two-dimensional porous system A better insight into the nature of I can be achieved by the application of topological approach. The topology is an 8-connected uninodal hex with the ooint svmbol of (36.418.53.6). The overall structure of 1 comprises of two independent interpenetrated networks niaybe due to the lenghth bpdc linker (fig. 3). In order to prepale nanoparticles of 1, the top-down approach was used, and the effect of, concentration, tinre of exposure and power of ultrasound were investigated. In order to make it brief the optimurn result which is gain at 72o/o of power and 15 min exposu'e with ultrasound irradiation is presented and it's SEM inrage depicted in fig. 4. The PXRD pattern of the obtained nanoparticles is similar to the as-synthesized and also flom the simulated single-clystal structures showing no structural defbrrration in nanoparticle preparation. Fig. L ORTEP plot ofthe Zn(ll) and bpdc linker Fig. 3. The two-fold interpenetrated nefwork s'ith hex topology SRPioneers @ Science and Research Pioneers Institute (wgw.sr.proneers.org) lnd fnttrrnational (.]on{ererrce on Nanot!-chnology ilCN 1it14), 1t}-l I Juiy 1014. Istanbrrl. Turl,:".rr As a matter of fact, drug carrier systems should be biocornpatible with minimal cytotoxicity. In ordel to test tlre potential in vitro cytotoxic effect ofbpdc, t and ZnO compounds and with this in mind that most cancer cells are from epithelial origin, normal epithelial cells were employed for assessment of their cytotoxicify over normal cellular compartment. To evaluate the toxicity of bpdc, I and ZnO courpounds, human amniotic epithelial cells were treated with different concentrations of these conrpounds for differ-ent time intervals of 24-72 h. As depicted in fig. 5, biphenyl dicarboxylic acid and zrnc oxide exhibited negligible cytotoxicity of under 5o/o over the all time periods examined. Impoltantly, MOFs as drug-delivery nanocaniers are highlydesirable due to their large loading of drugs, biodegladability and versatile flinctionaliry [6]. Owing to the accessible porosity and the window size (5 x 8 A) of 1, it is potentially useful in the encapsulation of small drug molecules. 5-Fluorouracil (5-FU, 3 * 6 A) is specifically chosen in the study for its small size, which is widely used as an anti-cancer chemothelapy drug for the treatment of colorectal, breast and head and neck cancers [7]. 1 showed remarkable 5-FU adsorption and the loading content was Fig. 4. Thc SEM imagc ofthc prcparcd nanoparticlcs. + 24n -l- 48h 72n ;e measured to be 22.82o/o by UV,n/is measurement. The kinetic process of5-FU delivery in simulated body fluid at 37"C is shown in Fig. 6. Arourrd 40% of the loaded 5-FU was released during the initial fast release (12 h), and 43.5% within 24 houls (Fig. 6). Compared with other MOFs calriels, I shows a fast release rate of 5-FU. bpdc (pM) + + + 24n 48h 45 , l 40i 72h c 9,. s E:o 0.01 0.1 1 compound 10 100 t (pM) 1001 10 + + + -J o 1000 *01 ?dh $8h 73h T t0 0510152023 nme (h) Fig. 6. The release process of5-FU frorr the drug-loaded t0 0+- Fig.5. Cytotoxiciry asscssment ol'bpdc. 0 I ------- I and ZrrO conrpounds 1 ii ,ihtfu SRPioneers @ Science and Research Pioneers Institute (wrrw.srpionecrs.org) I0-lllui.vl0l.l. I<rrnhrrl.Turl;r1' lnrllnternrtional {:lontercnceonN;rnolcclrnology(l(lNl0l4), ACKNowLEDGMENT Financial suppoft of the project by the Alzahra University is grateflilly acknowledged. REFERENCES tl] S. Henke, A. Schneemann, A. Wiitscher, R.A. Fischer, "Directing thc brcathing bchavior of pillarcd-laycred mctal-organic frameworks via a systematic library of functionalized linkers bcaring flcxiblc substitucnts", J. Am. Chcrn. Soc. Vol. 134 pp. 9464-9474,20t2. Lzl [3] H. Li, M. Eddaoudi, M. O'Kccffe, O. M. Yaghi, "Dcsign and synthesis of an exceptionally stable and highly porous metalorganic framework", Nature. Vol. 402 pp. 276-279,1999. P. Horcajada, R. Cre{ T. Baati, P. K. Allan, G. Maurin, P. Couvreur, G. Ferey, R. E. Monis, C. Sere, "Metal-organic framcworks in biomcdicinc" Chcm. Rcv. vol. 112, pp. 1232-1268, 2012. t4l S. A. Sapchcnko, D. N. Dybtsev, D. G. Samsonenko, V. P. Fedin, "Synthesis, crystal structures, luminescent and themal propeI1ies of two new metal-organic coordination polyners based on zinc (ll) carboxylates:" New. J. Chem. Vol. 34, pp. 2445-2450,2010 tsl A. L.Spck, "Singlc-crystal structurc validation"J. Appl. Crystallogr. Vol. 36, pp. 7-13,2003. [6) Z.Y. Gu, Y. J. Chcn, J. Q. Jiang and X. P. Yan, "Metal-organic frameworks for efficient enrichment ofpeptides with simultaneous exciusion of proteins from conrplex biological sanrples" Chem. Comnrun., vol. 47 , pp.4'1 87 -4789,2011. D, Wyatt and D. M. Wilson, "Participation of DNA repair in thc rcsponsc to 5-fluorouracil" Ccll. Mol. Lifb Sci., vol. 66, pp. 11) M. 7 88-799,2009.